Skip to main content
. Author manuscript; available in PMC: 2023 Sep 5.
Published in final edited form as: J Nat Prod. 2022 Mar 15;85(3):657–665. doi: 10.1021/acs.jnatprod.2c00015

Figure 4.

Figure 4.

Inhibition of SARS-CoV-2 infection in human lung cancer Calu-3 cells, performed as for Figure 3. Calu-3 cells were treated with the indicated compounds in a final concentration of 1% DMSO. Mean of two independent experiments shown with standard error of the mean.